Contents

Current Signal Transduction Therapy, Volume 9 - Number 1

Bortezomib and Arsenious Acid Synergistically Inhibit HL-60 Cells Viability in vitro and in vivo

, 9(1): 1 - 8

Yunbi Fu, Li li, Qixin Sun and Fanyi Meng


DOI: 10.2174/157436240901140924101815




miR-629-3p Level Significantly Predicts Prognosis in Glioblastoma Patients Treated with Temozolomide Chemotherapy

, 9(1): 9 - 14

Chen Hui-Yuan, Li Wen-Bin, Zhang Chuan-Bao, Zhang Wei and Zheng Hu-Yong


DOI: 10.2174/1574362409999140707103609




Fibroblast Growth Factor Receptor Signaling in Cancer Biology and Treatment

, 9(1): 15 - 25

Melanie Heroult, Peter Ellinghaus, Stuart Ince and Matthias Ocker


DOI: 10.2174/157436240901140924103836




Chinese Medicine: A Novel Therapeutic Option for Pancreatic Cancer

, 9(1): 26 - 31

Ping Yan, Yongxing Cao and Xiaotian Sun


DOI: 10.2174/157436240901140924103948




Perspective of MiRNAs in Clinical Glioblastoma Research

, 9(1): 32 - 37

Chunming Xiu, Wenwen Qi, Yunbo Wang, Hongtao Zhang and Nan Chi


DOI: 10.2174/1574362409666140724183754




A Hypothesis for Regenerative Therapy for Neuronal Disease: Stem Cells within Artificial Niche

, 9(1): 38 - 43

Jialin Liu, Zhiwen Zhang, Jinghui Xue, Haitao Zhang, Yuxiao Liu and Fengyun Hu


DOI: 10.2174/1574362409666140820225940




Analysis of Clinicopathological Characteristics and Prognosis of 1425 Primary Breast Cancer Patients in Eastern Guangdong, China

, 9(1): 44 - 49

Wen-He Huang, Si-Qi Qiu, Jun-Dong Wu, Cai-Wen Du, Yu-Kun Cui and Guo-Jun Zhang


DOI: 10.2174/1574362409666140724183612




7-Difluoromethyl-5, 4’-Dimethoxygenistein Reverses LPC-Induced Apoptosis of HUVE-12 Cells Through Regulating Mitochondrial Apoptosis Pathway

, 9(1): 50 - 58

Shiwei Liu, Lesai Li, Jing Zhang, He Huang, Shuting Yang, Changjie Ren, Xiaohua Fu and Yong Zhang


DOI: 10.2174/157436240901140924105409




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science